This brand name is authorized in Brazil, Finland, Ireland, Malta, Netherlands, New Zealand, Singapore
The drug CITANEST OCTAPRESSIN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Prilocaine
UNII MJW015BAPH - PRILOCAINE HYDROCHLORIDE
|
|
Prilocaine is a toluidine derivative and intermediate-acting amino amide with local anesthetic property. Prilocaine binds to the intracellular surface of sodium channels which blocks the subsequent influx of sodium into the cell. Action potential propagation and never function is, therefore, prevented. This block is reversible and when the drug diffuses away from the cell, sodium channel function is restored and nerve propagation returns. |
|
2
Felypressin
UNII 17N2918V6G - FELYPRESSIN
|
|
Felypressin is a synthetic hormone of the posterior pituitary lobe characterised by vasopressin-like properties. It is used as a vasoconstrictive agent in dental local anaesthetic solutions as an alternative to sympathomimetic agents (e.g. adrenaline). Felypressin has a low toxicity and is well tolerated by the tissues. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N01BB54 | Prilocaine, combinations | N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 528621040001607 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 009905, 009942 |
| Country: MT | Medicines Authority | Identifier(s): AA565/30603 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 772 |
| Country: SG | Health Sciences Authority | Identifier(s): 06175P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
